Addus HomeCare (NASDAQ:ADUS – Get Rating) had its target price dropped by analysts at Royal Bank of Canada from $125.00 to $111.00 in a research note issued to investors on Wednesday, The Fly reports. Royal Bank of Canada’s price target would indicate a potential upside of 34.81% from the company’s current price.
Other research analysts have also recently issued research reports about the stock. StockNews.com assumed coverage on shares of Addus HomeCare in a report on Thursday, March 31st. They issued a “buy” rating for the company. Bank of America assumed coverage on shares of Addus HomeCare in a report on Wednesday, April 13th. They issued a “buy” rating and a $110.00 price target for the company. Finally, Zacks Investment Research cut shares of Addus HomeCare from a “hold” rating to a “sell” rating in a report on Monday. One research analyst has rated the stock with a sell rating and four have given a buy rating to the stock. According to data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Buy” and a consensus target price of $105.50.
Shares of NASDAQ ADUS opened at $82.34 on Wednesday. The firm has a market capitalization of $1.32 billion, a PE ratio of 29.62, a P/E/G ratio of 2.21 and a beta of 0.87. Addus HomeCare has a 52-week low of $68.57 and a 52-week high of $108.11. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.76 and a current ratio of 2.76. The firm’s 50 day moving average price is $84.41.
In related news, CEO R Dirk Allison sold 1,911 shares of the stock in a transaction on Friday, February 25th. The shares were sold at an average price of $70.57, for a total transaction of $134,859.27. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Brian Poff sold 692 shares of the stock in a transaction on Friday, February 25th. The stock was sold at an average price of $70.58, for a total transaction of $48,841.36. The disclosure for this sale can be found here. Insiders have sold 5,196 shares of company stock valued at $398,605 in the last 90 days. 4.00% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC bought a new stake in Addus HomeCare during the first quarter worth $203,000. Financial Management Professionals Inc. bought a new stake in Addus HomeCare during the first quarter worth $72,000. Comerica Bank raised its position in Addus HomeCare by 3.0% during the first quarter. Comerica Bank now owns 13,826 shares of the company’s stock worth $1,272,000 after acquiring an additional 405 shares in the last quarter. ARGI Investment Services LLC raised its position in Addus HomeCare by 15.4% during the first quarter. ARGI Investment Services LLC now owns 30,191 shares of the company’s stock worth $2,817,000 after acquiring an additional 4,025 shares in the last quarter. Finally, Assenagon Asset Management S.A. bought a new stake in Addus HomeCare during the first quarter worth $4,244,000. 96.04% of the stock is currently owned by hedge funds and other institutional investors.
About Addus HomeCare (Get Rating)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
- Get a free copy of the StockNews.com research report on Addus HomeCare (ADUS)
- 3 Earnings Plays With Big Move Potential
- There Are Weeds In The Garden At Scotts Miracle-Gro
- It’s Time For FuboTV to Stand Out in the Sea of Streaming
- 3M Stock is Worth a Look Because of the Company it Keeps
- Landstar Systems Stock Can Bottom Down Here
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.